Product Code: ETC13169490 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Pulmonary Stents Market was valued at USD 0.35 Billion in 2024 and is expected to reach USD 0.52 Billion by 2031, growing at a compound annual growth rate of 5.70% during the forecast period (2025-2031).
The global pulmonary stents market is experiencing steady growth due to the increasing prevalence of respiratory diseases and the rising adoption of minimally invasive procedures. Pulmonary stents are used to treat conditions such as pulmonary artery stenosis, tracheal stenosis, and bronchial stenosis, providing relief to patients with compromised airways. Technological advancements in stent design and materials are driving market expansion, with an emphasis on improving stent flexibility, durability, and biocompatibility. Key market players are investing in research and development to introduce innovative products and expand their market presence. Geographically, North America holds a significant market share due to a high prevalence of respiratory diseases and well-established healthcare infrastructure. However, Asia Pacific is expected to witness rapid growth driven by increasing healthcare expenditure and improving access to advanced medical technologies.
The Global Pulmonary Stents Market is witnessing a growing demand due to the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and lung cancer. Key trends in the market include the development of innovative stent designs with improved biocompatibility and drug-eluting capabilities for better patient outcomes. Additionally, the rising adoption of minimally invasive procedures and advancements in technology are driving market growth. Opportunities in the market lie in the expanding geriatric population, increasing healthcare expenditure, and growing awareness about respiratory diseases. Market players are focusing on strategic collaborations, product launches, and geographical expansion to capitalize on these trends and opportunities in the Global Pulmonary Stents Market.
The Global Pulmonary Stents Market faces several challenges, including limited awareness about pulmonary stents among both patients and healthcare professionals, leading to underdiagnosis and underutilization of these devices. Additionally, the high cost of pulmonary stent procedures and the lack of reimbursement options in some regions hinder market growth. The presence of alternative treatment options for pulmonary conditions, such as medication and traditional surgical methods, also poses a challenge to the widespread adoption of pulmonary stents. Furthermore, regulatory hurdles and the need for specialized training for healthcare providers to perform pulmonary stent procedures effectively contribute to the challenges faced by the Global Pulmonary Stents Market. Overcoming these barriers will be crucial for market expansion and increased acceptance of pulmonary stents as a viable treatment option for respiratory diseases.
The Global Pulmonary Stents Market is primarily driven by the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and lung cancer, which require stent placement to maintain airway patency. Additionally, the growing aging population susceptible to respiratory conditions, advancements in stent design and materials leading to improved efficacy and reduced complications, and the rising adoption of minimally invasive procedures are contributing to the market growth. Moreover, the expanding awareness about pulmonary stents among healthcare professionals and patients, along with the increasing healthcare expenditure in developing regions, are further fueling the demand for pulmonary stents globally. These factors collectively are expected to propel the growth of the Global Pulmonary Stents Market in the coming years.
Government policies related to the Global Pulmonary Stents Market primarily focus on regulatory approvals and quality standards to ensure the safety and efficacy of pulmonary stents. Regulatory bodies such as the FDA in the United States and the European Medicines Agency (EMA) in Europe have established stringent guidelines for the approval of pulmonary stents, requiring manufacturers to conduct thorough clinical trials and demonstrate the product`s safety and effectiveness. Additionally, government policies aim to promote innovation and competition in the market by streamlining the approval processes for new stent technologies while also monitoring post-market surveillance to address any safety concerns promptly. These policies play a crucial role in shaping the competitive landscape of the Global Pulmonary Stents Market and safeguarding patient health outcomes.
The Global Pulmonary Stents Market is expected to witness steady growth in the coming years due to the rising prevalence of respiratory disorders and the increasing adoption of minimally invasive procedures. The market is driven by advancements in stent technology, such as the development of drug-eluting stents and bioresorbable stents, which offer improved patient outcomes. Additionally, the aging population, growing healthcare infrastructure in emerging economies, and the rising awareness about pulmonary stents are likely to further propel market growth. However, challenges such as the high cost of treatment and potential complications associated with stent placement may hinder market expansion. Overall, the Global Pulmonary Stents Market is anticipated to experience continued growth, driven by technological innovations and increasing demand for minimally invasive treatments for respiratory conditions.
In the Global Pulmonary Stents Market, North America leads in terms of market share due to the high prevalence of respiratory diseases and well-established healthcare infrastructure. Europe follows closely behind, driven by increasing awareness about advanced treatment options and favorable reimbursement policies. Asia-Pacific is poised for significant growth with improving healthcare facilities and rising adoption of minimally invasive procedures. The Middle East and Africa region is experiencing steady growth supported by investments in healthcare infrastructure and increasing patient population. Latin America shows promising growth opportunities due to the expanding healthcare sector and growing awareness about respiratory diseases. Overall, the global pulmonary stents market is expected to witness substantial growth across all regions, driven by technological advancements and increasing prevalence of respiratory disorders.
Global Pulmonary Stents Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Pulmonary Stents Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Pulmonary Stents Market Revenues & Volume, 2021 & 2031F |
3.3 Global Pulmonary Stents Market - Industry Life Cycle |
3.4 Global Pulmonary Stents Market - Porter's Five Forces |
3.5 Global Pulmonary Stents Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Pulmonary Stents Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Pulmonary Stents Market Revenues & Volume Share, By Material, 2021 & 2031F |
3.8 Global Pulmonary Stents Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 Global Pulmonary Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Pulmonary Stents Market Trends |
6 Global Pulmonary Stents Market, 2021 - 2031 |
6.1 Global Pulmonary Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Pulmonary Stents Market, Revenues & Volume, By Self-expandable Stents, 2021 - 2031 |
6.1.3 Global Pulmonary Stents Market, Revenues & Volume, By Balloon-expandable Stents, 2021 - 2031 |
6.2 Global Pulmonary Stents Market, Revenues & Volume, By Material, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Pulmonary Stents Market, Revenues & Volume, By Metal, 2021 - 2031 |
6.2.3 Global Pulmonary Stents Market, Revenues & Volume, By Silicon, 2021 - 2031 |
6.2.4 Global Pulmonary Stents Market, Revenues & Volume, By Hybrid, 2021 - 2031 |
6.3 Global Pulmonary Stents Market, Revenues & Volume, By Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Pulmonary Stents Market, Revenues & Volume, By Tracheobronchial Stents, 2021 - 2031 |
6.3.3 Global Pulmonary Stents Market, Revenues & Volume, By Laryngeal Stents, 2021 - 2031 |
7 North America Pulmonary Stents Market, Overview & Analysis |
7.1 North America Pulmonary Stents Market Revenues & Volume, 2021 - 2031 |
7.2 North America Pulmonary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Pulmonary Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Pulmonary Stents Market, Revenues & Volume, By Material, 2021 - 2031 |
7.5 North America Pulmonary Stents Market, Revenues & Volume, By Type, 2021 - 2031 |
8 Latin America (LATAM) Pulmonary Stents Market, Overview & Analysis |
8.1 Latin America (LATAM) Pulmonary Stents Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Pulmonary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Pulmonary Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Pulmonary Stents Market, Revenues & Volume, By Material, 2021 - 2031 |
8.5 Latin America (LATAM) Pulmonary Stents Market, Revenues & Volume, By Type, 2021 - 2031 |
9 Asia Pulmonary Stents Market, Overview & Analysis |
9.1 Asia Pulmonary Stents Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Pulmonary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Pulmonary Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Pulmonary Stents Market, Revenues & Volume, By Material, 2021 - 2031 |
9.5 Asia Pulmonary Stents Market, Revenues & Volume, By Type, 2021 - 2031 |
10 Africa Pulmonary Stents Market, Overview & Analysis |
10.1 Africa Pulmonary Stents Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Pulmonary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Pulmonary Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Pulmonary Stents Market, Revenues & Volume, By Material, 2021 - 2031 |
10.5 Africa Pulmonary Stents Market, Revenues & Volume, By Type, 2021 - 2031 |
11 Europe Pulmonary Stents Market, Overview & Analysis |
11.1 Europe Pulmonary Stents Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Pulmonary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Pulmonary Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Pulmonary Stents Market, Revenues & Volume, By Material, 2021 - 2031 |
11.5 Europe Pulmonary Stents Market, Revenues & Volume, By Type, 2021 - 2031 |
12 Middle East Pulmonary Stents Market, Overview & Analysis |
12.1 Middle East Pulmonary Stents Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Pulmonary Stents Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Pulmonary Stents Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Pulmonary Stents Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Pulmonary Stents Market, Revenues & Volume, By Material, 2021 - 2031 |
12.5 Middle East Pulmonary Stents Market, Revenues & Volume, By Type, 2021 - 2031 |
13 Global Pulmonary Stents Market Key Performance Indicators |
14 Global Pulmonary Stents Market - Export/Import By Countries Assessment |
15 Global Pulmonary Stents Market - Opportunity Assessment |
15.1 Global Pulmonary Stents Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Pulmonary Stents Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Pulmonary Stents Market Opportunity Assessment, By Material, 2021 & 2031F |
15.4 Global Pulmonary Stents Market Opportunity Assessment, By Type, 2021 & 2031F |
16 Global Pulmonary Stents Market - Competitive Landscape |
16.1 Global Pulmonary Stents Market Revenue Share, By Companies, 2024 |
16.2 Global Pulmonary Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |